Literature DB >> 20729198

SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.

Reiko M Onishi1, Sangmi J Park, Walter Hanel, Allen W Ho, Amarnath Maitra, Sarah L Gaffen.   

Abstract

IL-17, the hallmark cytokine of the Th17 population, mediates immunity to extracellular pathogens and promotes autoimmune immunopathology. The signaling mechanisms triggered by the IL-17 receptor (IL-17RA) and related receptors are strikingly different from other cytokine subclasses. Namely, IL-17Rs contain a conserved SEF/IL-17R (SEFIR) subdomain that engages Act1, leading to activation of TRAF6, NF-κB, and other events. Although the SEFIR is critical for signaling, the molecular details of the functional subdomains within IL-17RA remain poorly characterized. Here, we provide a detailed structure-function analysis delineating the C-terminal boundary of the SEFIR-containing region of IL-17RA. We show that functionality of this domain requires a large extension to the previously identified SEFIR motif. In contrast to the SEFIR, this extension is not conserved among IL-17R family members. Surprisingly, Act1 recruitment is not sufficient for downstream signaling activation, whereas ubiquitination of TRAF6 correlates tightly with functional receptors. We further demonstrate that IL-17RA exhibits signaling properties that are nonredundant with other IL-17R family members. Finally, we report that IL-17 signals synergistically with lymphotoxin-α3, using the same signaling motifs within IL-17RA. These studies provide new insight into the structure-function relationships of IL-17RA and reveal distinct signaling differences among IL-17R family members.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729198      PMCID: PMC2963341          DOI: 10.1074/jbc.M110.121418

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.

Authors:  Pierre Miossec
Journal:  Arthritis Rheum       Date:  2003-03

Review 2.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

3.  Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

Authors:  Z Yao; W C Fanslow; M F Seldin; A M Rousseau; S L Painter; M R Comeau; J I Cohen; M K Spriggs
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

Review 4.  IL-17: prototype member of an emerging cytokine family.

Authors:  Sudeepta Aggarwal; Austin L Gurney
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

5.  IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.

Authors:  Allen W Ho; Fang Shen; Heather R Conti; Nayan Patel; Erin E Childs; Alanna C Peterson; Nydiaris Hernández-Santos; Jay K Kolls; Lawrence P Kane; Wenjun Ouyang; Sarah L Gaffen
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.

Authors:  Matthew J Ruddy; Fang Shen; Jeffrey B Smith; Ashu Sharma; Sarah L Gaffen
Journal:  J Leukoc Biol       Date:  2004-04-23       Impact factor: 4.962

Review 7.  The STIR-domain superfamily in signal transduction, development and immunity.

Authors:  Maria Novatchkova; Andreas Leibbrandt; Johannes Werzowa; Annette Neubüser; Frank Eisenhaber
Journal:  Trends Biochem Sci       Date:  2003-05       Impact factor: 13.807

8.  Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members.

Authors:  Matthew J Ruddy; Grace C Wong; Xikui K Liu; Hiroyasu Yamamoto; Soji Kasayama; Keith L Kirkwood; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

9.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.

Authors:  F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction.

Authors:  R Schwandner; K Yamaguchi; Z Cao
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

View more
  26 in total

Review 1.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

2.  Life before seventeen: cloning of the IL-17 receptor.

Authors:  Sarah L Gaffen
Journal:  J Immunol       Date:  2011-11-01       Impact factor: 5.422

3.  Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL.

Authors:  Baojun Wu; Meng Jin; Yi Zhang; Tiandi Wei; Zengliang Bai
Journal:  Immunogenetics       Date:  2011-07-06       Impact factor: 2.846

Review 4.  Recent advances in the IL-17 cytokine family.

Authors:  Sarah L Gaffen
Journal:  Curr Opin Immunol       Date:  2011-08-16       Impact factor: 7.486

5.  RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling.

Authors:  Wenlong Lin; Ning Wang; Kangxing Zhou; Fasheng Su; Yu Jiang; Jianan Shou; Huan Liu; Chunmei Ma; Youchun Qian; Kai Wang; Xiaojian Wang
Journal:  EMBO Rep       Date:  2018-04-19       Impact factor: 8.807

Review 6.  Signaling of interleukin-17 family cytokines in immunity and inflammation.

Authors:  Seon Hee Chang; Chen Dong
Journal:  Cell Signal       Date:  2010-12-02       Impact factor: 4.315

7.  An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.

Authors:  Chunsheng Zhou; Leticia Monin; Rachael Gordon; Felix E Y Aggor; Rami Bechara; Tara N Edwards; Daniel H Kaplan; Sebastien Gingras; Sarah L Gaffen
Journal:  J Immunol       Date:  2020-06-29       Impact factor: 5.422

8.  IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.

Authors:  Hye-Lin Ha; Hongshan Wang; Prapaporn Pisitkun; Jin-Chul Kim; Ilaria Tassi; Wanhu Tang; Maria I Morasso; Mark C Udey; Ulrich Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors.

Authors:  Mushtaq Ahmed; Sarah L Gaffen
Journal:  Cytokine       Date:  2013-01-16       Impact factor: 3.861

10.  The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.

Authors:  Abhishek V Garg; Mushtaq Ahmed; Abbe N Vallejo; Averil Ma; Sarah L Gaffen
Journal:  Sci Signal       Date:  2013-06-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.